Oligonucleotide Synthesis Market Is Witnessing Robust Growth With Agilent Technologies Announcing To Invest Us$ 150 Million To Double Its Production Capacity For Oligonucleotides In Colorado, U.S.
Oligonucleotide Synthesis is the direct physical expression of a nucleic acid chain reaction that results in the generation of a DNA sequence by random synthesis. Oligonucleotides are very long sequences of DNA that are helical in nature. Nucleic acid is the genetic material that makes up DNA, the building block of life. It is a highly complex material composed of various amino acids, sugars, and other molecules. It is a system that can be studied at the molecular level and used for biochemistry research and development. Developed countries such as the U.S. and Canada have a strong foothold in the oligonucleotide synthesis market. This is typically due to the fact there are rapid growth of genomics, oncology, diagnostic screening, and drug discovery sectors. On the contrary, emerging regions including Asia Pacific seem to be gaining major traction with rapid progress in genomics studies in the healthcare sector and rising investments. The use of synthesized oligos in t...